Part I: Testicular cancer-management of early disease

By Jones R.H.   Vasey P.A.  

Lancet Oncology, Vol. 4, Iss. 12, 2003-12 ,pp. : 730-737

Elsevier

Access to resources Recommend Favorite

Controversies in Testicular Cancer Management

By Horwich A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 840-841

Elsevier

Access to resources Recommend Favorite

Diagnosis and local management of breast cancer: part II

By Benson John R  

Future Oncology, Vol. 7, Iss. 8, 2011-08 ,pp. : 959-961

Future Medicine

Access to resources Recommend Favorite

Efficacy, tolerability and management of raltitrexed (Tomudex&unknown;) monotherapy in patients with advanced colorectal cancer - a review of phase II/III trials

By Cunningham D.   Zalcberg J.   Maroun J.   James R.   Clarke S.   Maughan T.S.   Vincent M.   Schulz J.   Gonzalez Baron M.   Facchini T.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 478-486

Elsevier

Access to resources Recommend Favorite

Kidney cancer: The cytokine working group experience (1986–2001): Part II: Management of IL-2 toxicity and studies with other cytokines

By Dutcher Janice   Atkins Michael   Margolin Kim   Weiss Geoff   Clark Joseph   Sosman Jeff   Logan Theodore   Aronson Fred   Mier James  

Medical Oncology, Vol. 18, Iss. 3, 2001-09 ,pp. : 209-219

Humana Press, Inc

Access to resources Recommend Favorite